These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7268693)

  • 1. Responses of rabbit platelets to adrenaline induced by other agonists.
    Hallam TJ; Scrutton MC; Wallis RB
    Thromb Res; 1981 Feb 15-Mar 1; 21(4-5):413-24. PubMed ID: 7268693
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet activation induced by a stable analogue of endoperoxides (U46619).
    Zatta A; Prosdocimi M
    Thromb Haemost; 1989 Apr; 61(2):328-9. PubMed ID: 2526389
    [No Abstract]   [Full Text] [Related]  

  • 4. Desensitisation in human and rabbit blood platelets.
    Hallam TJ; Ruggles PA; Scrutton MC; Wallis RB
    Thromb Haemost; 1982 Jun; 47(3):278-84. PubMed ID: 7112500
    [No Abstract]   [Full Text] [Related]  

  • 5. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S; Westwick J; Kakkar VV
    Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
    Connolly TM; Limbird LE
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereo-dependent inhibition of human platelet function by the optical isomers of trimetoquinol.
    Mayo JR; Navran SS; Huzoor-Akbar ; Miller DD; Feller DR
    Biochem Pharmacol; 1981 Aug; 30(16):2237-41. PubMed ID: 7188564
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate.
    Cattaneo M; Lecchi A; Randi AM; McGregor JL; Mannucci PM
    Blood; 1992 Dec; 80(11):2787-96. PubMed ID: 1333302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A method for quantitating platelet aggregation and analyzing drug-receptor interactions on platelets in whole blood in vitro.
    Lumley P; Humphrey PP
    J Pharmacol Methods; 1981 Sep; 6(2):153-66. PubMed ID: 7289632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
    Krishnamurthi S; Joseph S; Kakkar VV
    Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Succinate potentiates the action of platelet agonists.
    Huang EM; McGowan EB; Detwiler TC
    Thromb Res; 1984 Oct; 36(1):1-8. PubMed ID: 6095483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboxane A2 and the endoperoxides mediate canine platelet activation.
    Harris RH; Nichols R; Schmeling JW; Ramwell PW
    Thromb Res; 1981 Sep; 23(6):521-32. PubMed ID: 6798707
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiplatelet actions of 2-(4-[1-(2-chlorophenyl) piperazinyl]) methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one compound.
    Ding YA; Chou TC; Chern JW; Yen MH
    Thromb Res; 1995 Feb; 77(3):291-303. PubMed ID: 7740521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of thromboxane A2.
    Ambler J; Birch J; Maguire ED; Wallis RB
    Adv Exp Med Biol; 1985; 192():293-308. PubMed ID: 2939695
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of the P2-purinoceptor antagonist, suramin, on human platelet aggregation induced by adenosine 5'-diphosphate.
    Hourani SM; Hall DA; Nieman CJ
    Br J Pharmacol; 1992 Feb; 105(2):453-7. PubMed ID: 1559134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell response kinetics: the phenomenon of supercooperativity in aggregation of human platelets.
    Vrzheshch PV; Tatarintsev AV; Yershov DE; Varfolomeyev SD
    Thromb Res; 1992 Jun; 66(5):537-47. PubMed ID: 1523610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro.
    Lumley P; White BP; Humphrey PP
    Br J Pharmacol; 1989 Jul; 97(3):783-94. PubMed ID: 2527074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets.
    Radomski MW; Palmer RM; Moncada S
    Br J Pharmacol; 1987 Sep; 92(1):181-7. PubMed ID: 3311265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of protein kinase C in U46619-induced platelet shape change, aggregation and secretion.
    Nakano T; Hanasaki K; Arita H
    Thromb Res; 1989 Oct; 56(2):299-306. PubMed ID: 2617470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of heat on platelet biochemistry, structure, and function.
    Rao GH; Smith CM; Escolar G; White JG
    J Lab Clin Med; 1993 Oct; 122(4):455-64. PubMed ID: 8228561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.